Strides Pharma Science has informed about submission of Press Release issued by the Company titled ‘Strides to acquire 80% stake in Pharmapar Inc. to build out its Canadian Operations’. Also, enclosed is the disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 on the said transaction.
The above information is a part of company’s filings submitted to BSE.